Cargando…
A Short Half-Life α(IIb)β(3) Antagonist ANTP266 Reduces Thrombus Formation
Integrin α(IIb)β(3) plays a pivotal role in platelet aggregation. Three α(IIb)β(3) antagonists have been approved by the Food and Drug Administration (FDA) for the treatment of cardiovascular diseases. Unfortunately, all of these three drugs can cause the side effect of severe bleeding. Therefore, d...
Autores principales: | Liu, Tong-Dan, Ren, Shen-Hong, Ding, Xue, Xie, Zhou-Ling, Kong, Yi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6121621/ https://www.ncbi.nlm.nih.gov/pubmed/30082659 http://dx.doi.org/10.3390/ijms19082306 |
Ejemplares similares
-
A Naphthalenic Derivative ND-1 Inhibits Thrombus Formation by Interfering the Binding of Fibrinogen to Integrin αIIbβ3
por: Ding, Xue, et al.
Publicado: (2016) -
Protein evolution of ANTP and PRD homeobox genes
por: Fonseca, Nuno A, et al.
Publicado: (2008) -
MMP‐13 binds to platelet receptors αIIbβ3 and GPVI and impairs aggregation and thrombus formation
por: Howes, Joanna‐Marie, et al.
Publicado: (2018) -
Reversible Platelet Integrin αIIbβ3 Activation and Thrombus Instability
por: Zou, Jinmi, et al.
Publicado: (2022) -
β(3) phosphorylation of platelet α(IIb)β(3) is crucial for stability of arterial thrombus and microparticle formation in vivo
por: Feng, Weiyi, et al.
Publicado: (2017)